Literature DB >> 27573937

Short-term Effects of Laparoscopic Adjustable Gastric Banding Versus Roux-en-Y Gastric Bypass.

Amalia Gastaldelli1, Amerigo Iaconelli2, Melania Gaggini3, Maria Chiara Magnone4, Augusto Veneziani2, Francesco Rubino5, Geltrude Mingrone2,5.   

Abstract

OBJECTIVE: Bariatric surgery has been shown to have important long-term metabolic effects resulting in enhanced insulin sensitivity and improved glucose tolerance in patients with type 2 diabetes. The contribution of reduced caloric intake to these beneficial effects of surgery remains unclear. The aim of this study was to compare the short-term effects (1 week) of bariatric surgical procedures with a very low caloric intake (VLCI) on insulin sensitivity (IS) and insulin secretion (ISR) in nondiabetic obese subjects. RESEARCH DESIGN AND METHODS: Twenty obese patients without diabetes (BMI 44.2 ± 0.7 kg/m2) were admitted to the clinic for 1 week. At baseline and 1 week after VLCI (600 kcal/day), subjects received a hyperinsulinemic-euglycemic clamp with tracer infusion to quantify endogenous glucose production (EGP), lipolysis (rate of appearance of glycerol [RaGlycerol]), peripheral insulin sensitivity (insulin-stimulated glucose disposal [M value] divided by the steady-state plasma insulin concentration [M/I]), hepatic insulin sensitivity (Hep-IS [= 1/(EGP ⋅ insulin)]), and adipose insulin sensitivity (Adipo-IS [= 1/(RaGlycerol ⋅ insulin)]). An intravenous glucose bolus was administered at the end of the insulin clamp to measure ISR and β-cell function (disposition index [DI]). Approximately 3 months later, patients were admitted for laparoscopic adjustable gastric banding (LAGB) (n = 10) or Roux-en-Y gastric bypass (RYGB) (n = 10), and were restudied 1 week after surgery under the same caloric regimen (600 kcal/day).
RESULTS: After 1 week of VLCI, patients lost 2.1 kg without significant changes in Hep-IS, Adipo-IS, M/I, or DI. RYGB and LAGB led to greater weight loss (5.5 and 5.2 kg, respectively) and to significant improvement in Hep-IS, EGP, and lipolysis. Only RYGB improved Adipo-IS and M/I. No change in ISR or DI was observed in either surgical group.
CONCLUSIONS: Bariatric surgery improves IS within 1 week. These metabolic effects were independent of caloric intake and more pronounced after RYGB compared with LAGB.
© 2016 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27573937     DOI: 10.2337/dc15-2823

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  21 in total

1.  Type 2 Diabetes Remission After Roux-en-Y Gastric Bypass: Evidence for Increased Expression of Jejunal Genes Encoding Regenerating Pancreatic Islet-Derived Proteins as a Potential Mechanism.

Authors:  Priscila Sala; Raquel Susana Torrinhas; Danielle Cristina Fonseca; Steven Heymsfield; Daniel Giannella-Neto; Dan Linetzky Waitzberg
Journal:  Obes Surg       Date:  2017-04       Impact factor: 4.129

2.  Sleeve gastrectomy rapidly enhances islet function independently of body weight.

Authors:  Jonathan D Douros; Jingjing Niu; Sophia Sdao; Trillian Gregg; Kelsey Fisher-Wellman; Manish Bharadwaj; Anthony Molina; Ramamani Arumugam; MacKenzie Martin; Enrico Petretto; Matthew J Merrins; Mark A Herman; Jenny Tong; Jonathan Campbell; David D'Alessio
Journal:  JCI Insight       Date:  2019-03-21

Review 3.  Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?

Authors:  Jean Debédat; Chloé Amouyal; Judith Aron-Wisnewsky; Karine Clément
Journal:  Semin Immunopathol       Date:  2019-04-25       Impact factor: 9.623

4.  Slc43a3 is a regulator of free fatty acid flux.

Authors:  Kathrin B Hasbargen; Wen-Jun Shen; Yiqiang Zhang; Xiaoming Hou; Wei Wang; Qui Shuo; David A Bernlohr; Salman Azhar; Fredric B Kraemer
Journal:  J Lipid Res       Date:  2020-03-26       Impact factor: 5.922

5.  Defining Short-term, Medium-term, Long-term, and Very Long-term Follow-up After Bariatric Surgery.

Authors:  Kamal K Mahawar
Journal:  Obes Surg       Date:  2018-05       Impact factor: 4.129

6.  Effect of Surgical Versus Medical Therapy on Diabetic Kidney Disease Over 5 Years in Severely Obese Adolescents With Type 2 Diabetes.

Authors:  Petter Bjornstad; Kara Hughan; Megan M Kelsey; Amy S Shah; Jane Lynch; Edward Nehus; Mark Mitsnefes; Todd Jenkins; Peixin Xu; Changchun Xie; Thomas Inge; Kristen Nadeau
Journal:  Diabetes Care       Date:  2019-11-04       Impact factor: 19.112

7.  The Effects of Bariatric Surgery on Islet Function, Insulin Secretion, and Glucose Control.

Authors:  Jonathan D Douros; Jenny Tong; David A D'Alessio
Journal:  Endocr Rev       Date:  2019-10-01       Impact factor: 19.871

8.  Length of biliopancreatic limb in Roux-en-Y gastric bypass and its impact on post-operative outcomes in metabolic and obesity surgery-systematic review and meta-analysis.

Authors:  Anna Kamocka; Swathikan Chidambaram; Simon Erridge; Gauri Vithlani; Alexander Dimitri Miras; Sanjay Purkayastha
Journal:  Int J Obes (Lond)       Date:  2022-08-04       Impact factor: 5.551

Review 9.  Bariatric surgery and kidney disease outcomes in severely obese youth.

Authors:  Petter Bjornstad; Edward Nehus; Daniel van Raalte
Journal:  Semin Pediatr Surg       Date:  2020-01-20       Impact factor: 2.754

10.  Metabolic shift precedes the resolution of inflammation in a cohort of patients undergoing bariatric and metabolic surgery.

Authors:  Jose Romeo Villarreal-Calderon; Ricardo Cuellar-Tamez; Elena C Castillo; Eder Luna-Ceron; Gerardo García-Rivas; Leticia Elizondo-Montemayor
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.